You have 9 free searches left this month | for more free features.

urothelial cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

Not yet recruiting
  • Urothelial Carcinoma
  • +7 more
  • Jelmyto (mitomycin) for pyelocalyceal solution
  • (no location specified)
May 22, 2023

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Bicalutamide 150 mg
  • Placebo
  • Québec, Canada
    CHU de Québec - Université Laval
Sep 6, 2023

Urothelial Cancer and Rare Genitourinary Tract Malignancies

Recruiting
  • Urothelial Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Care of Urothelial Cancer Patient and Prospective Procurement of

    Recruiting
    • Bladder Cancer
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Urothelial Carcinoma Trial (Avelumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • (no location specified)
      Oct 26, 2022

      Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

      Recruiting
      • Urothelial Cancer
      • Beijing, China
        Beijing Cancer Hospital
      Jan 18, 2023

      High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab

      Not yet recruiting
      • High Grade Urothelial Carcinoma
      • +2 more
      • Washington, District of Columbia
      • +1 more
      Jan 5, 2023

      HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

      Not yet recruiting
      • Urothelial Carcinoma
        • (no location specified)
        Jun 5, 2023

        Bladder Urothelial Carcinoma, Urothelial Carcinoma Trial in Philadelphia (Copper Cu 64 TP3805, Positron Emission Tomography,

        Active, not recruiting
        • Bladder Urothelial Carcinoma
        • Urothelial Carcinoma
        • Copper Cu 64 TP3805
        • +2 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Dec 13, 2022

        Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)

        Not yet recruiting
        • Urothelial Carcinoma Ureter
        • Urothelial Cancer of Renal Pelvis
        • Mitomycin C
        • (no location specified)
        Jul 31, 2023

        Urothelial Cancer Trial (pembrolizumab)

        Completed
        • Urothelial Cancer
        • pembrolizumab
        • (no location specified)
        Aug 18, 2022

        Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

        Not yet recruiting
        • Metastatic Cancer
        • +5 more
        • (no location specified)
        Jul 10, 2023

        Physical and Biological Effects of Upper Tract Urothelial Cancer

        Recruiting
        • Upper Tract Urothelial Cancer
          • Hong Kong, Hong Kong
            Prince of Wales Hospital
          Jun 29, 2022

          Avelumab in Real-World Treatment for Advanced or Metastatic

          Not yet recruiting
          • Bladder Cancer
          • (no location specified)
          Nov 21, 2022

          Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

          Active, not recruiting
          • Urothelial Carcinoma
          • Iowa City, Iowa
            University of Iowa Hospitals and Clinics
          Oct 18, 2022

          Urogenital Cancer Trial in London (Atezolizumab)

          Recruiting
          • Urogenital Cancer
          • London, United Kingdom
            Barts and London Hospital NHS Trust
          Aug 10, 2022

          Metastatic Urothelial Cancer Trial in Stockholm (MFA-370)

          Not yet recruiting
          • Metastatic Urothelial Cancer
          • Stockholm, Sweden
            Karolinska University Hospital
          May 19, 2022

          Urothelial Carcinoma Trial in Amsterdam, Nijmegen (Nivolumab)

          Recruiting
          • Urothelial Carcinoma
          • Amsterdam, Netherlands
          • +1 more
          Jul 28, 2022

          Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

          Not yet recruiting
          • Locally Advanced Bladder Urothelial Carcinoma
          • +31 more
          • Diagnostic Laboratory Biomarker Analysis
          • Nivolumab
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 18, 2022

          Advanced or Metastatic Urothelium Cancer Trial in Beijing (MRG002, Docetaxel Injection, Paclitaxel Injection)

          Not yet recruiting
          • Advanced or Metastatic Urothelium Cancer
          • Beijing, Beijing, China
            Cancer Hospital Chinese Academy of Medical Sciences
          Feb 22, 2023

          Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

          Active, not recruiting
          • Neoplasm
          • Beijing, China
          • +5 more
          Jan 31, 2023

          Metastatic Urothelial Cancer in Latin America

          Completed
          • Recurrent/Metastatic Urothelial Cancers
            • Salvador, BA, Brazil
            • +8 more
            Sep 26, 2022

            Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

            Not yet recruiting
            • Urothelial Carcinoma
            • disitamab vedotin
            • +4 more
            • (no location specified)
            Jun 9, 2023

            Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

            Terminated
            • Urothelial Carcinoma
            • Phoenix, Arizona
            • +7 more
            Dec 15, 2022